PT871625E - Preparacao de triazoles por adicao organometalica a cetonas e intermediarios destas - Google Patents

Preparacao de triazoles por adicao organometalica a cetonas e intermediarios destas

Info

Publication number
PT871625E
PT871625E PT96927644T PT96927644T PT871625E PT 871625 E PT871625 E PT 871625E PT 96927644 T PT96927644 T PT 96927644T PT 96927644 T PT96927644 T PT 96927644T PT 871625 E PT871625 E PT 871625E
Authority
PT
Portugal
Prior art keywords
organomethalic
cetonas
intermediaries
triazoles
preparation
Prior art date
Application number
PT96927644T
Other languages
English (en)
Inventor
Michael Butters
Julie Ann Harrison
Alan John Pettman
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10778850&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT871625(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of PT871625E publication Critical patent/PT871625E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT96927644T 1995-08-05 1996-07-26 Preparacao de triazoles por adicao organometalica a cetonas e intermediarios destas PT871625E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9516121.2A GB9516121D0 (en) 1995-08-05 1995-08-05 Organometallic addition to ketones

Publications (1)

Publication Number Publication Date
PT871625E true PT871625E (pt) 2004-04-30

Family

ID=10778850

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96927644T PT871625E (pt) 1995-08-05 1996-07-26 Preparacao de triazoles por adicao organometalica a cetonas e intermediarios destas

Country Status (32)

Country Link
US (2) US6586594B1 (pt)
EP (1) EP0871625B1 (pt)
JP (3) JP3211965B2 (pt)
KR (1) KR100269048B1 (pt)
CN (1) CN1076019C (pt)
AR (1) AR003472A1 (pt)
AT (1) ATE256679T1 (pt)
AU (1) AU703337B2 (pt)
BR (1) BR9609960A (pt)
CA (1) CA2228655C (pt)
CZ (1) CZ296975B6 (pt)
DE (1) DE69631160T2 (pt)
DK (1) DK0871625T3 (pt)
EG (1) EG21200A (pt)
ES (1) ES2210382T3 (pt)
GB (1) GB9516121D0 (pt)
HK (1) HK1014944A1 (pt)
HU (1) HU224339B1 (pt)
IL (2) IL122462A (pt)
IN (1) IN190817B (pt)
MX (1) MX9801025A (pt)
MY (1) MY123062A (pt)
NO (1) NO314938B1 (pt)
NZ (1) NZ315651A (pt)
PE (1) PE16897A1 (pt)
PL (1) PL187227B1 (pt)
PT (1) PT871625E (pt)
RU (1) RU2156760C2 (pt)
TR (1) TR199800170T1 (pt)
TW (1) TW442480B (pt)
WO (1) WO1997006160A1 (pt)
ZA (1) ZA966587B (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193083B2 (en) * 1996-07-26 2007-03-20 Pfizer, Inc. Preparation of triazoles by organometallic addition to ketones and intermediates therefor
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
MXPA05001096A (es) 2002-07-29 2005-11-23 Rigel Pharmaceuticals Inc Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
US8178671B2 (en) * 2003-07-30 2012-05-15 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
US20060058525A1 (en) * 2004-09-01 2006-03-16 Rajinder Singh Synthesis of 2,4-pyrimidinediamine compounds
WO2006068770A1 (en) * 2004-11-24 2006-06-29 Rigel Pharmaceuticals, Inc. Spiro-2, 4-pyrimidinediamine compounds and their uses
WO2006065726A2 (en) * 2004-12-14 2006-06-22 Dr. Reddy's Laboratories Ltd. Process for preparing voriconazole
CA2604551A1 (en) * 2005-05-03 2007-03-08 Rigel Pharmaceuticals, Inc. Jak kinase inhibitors and their uses
CA2640922A1 (en) * 2006-02-01 2007-11-22 Medichem, S.A. Process for preparing voriconazole, new polymorphic form of intermediate thereof, and uses thereof
AR061889A1 (es) 2006-07-13 2008-10-01 Medichem Sa Proceso mejorado para la preparacion de voriconazol
CN1919846B (zh) * 2006-09-14 2013-01-02 大道隆达（北京）医药科技发展有限公司 伏立康唑及其药用盐、中间体的一种新定向合成制备方法
KR100889937B1 (ko) * 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
GB2452049A (en) * 2007-08-21 2009-02-25 Alpharma Aps Process for the preparation of voriconazole
WO2009084029A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for the preparation of (2r,3s)-2-(2,4- difluqrophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol
CN101575330B (zh) * 2008-05-05 2012-10-31 丽珠医药集团股份有限公司 伏立康唑广谱抗真菌药物化合物、其组合物及用途
US20110312977A1 (en) * 2009-02-17 2011-12-22 Glenmark Generics Limited Process for the preparation of voriconazole
KR101109215B1 (ko) 2009-06-17 2012-01-30 보령제약 주식회사 보리코나졸의 신규 중간체 및 이를 이용한 보리코나졸의 제조방법
EP2470529B1 (en) 2009-12-30 2014-11-19 Medichem, S.A. A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivate with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
KR100971371B1 (ko) 2010-02-04 2010-07-20 동국제약 주식회사 신규한 중간체를 이용한 보리코나졸의 제조방법
WO2011110198A1 (en) 2010-03-10 2011-09-15 Synthron B.V. A process for making voriconazole
CN101914091B (zh) * 2010-07-25 2015-05-27 浙江华海药业股份有限公司 一种制备伏立康唑中间体的方法
CN102344441B (zh) * 2010-07-25 2015-05-06 浙江华海药业股份有限公司 一种制备伏立康唑中间体的工艺改进方法
US20140350252A1 (en) 2011-02-21 2014-11-27 Nitin Maheshwari Process for the preparation of voriconazole and intermediates thereof
EP2720723B1 (en) 2011-06-15 2018-04-11 Synthon BV Stabilized voriconazole composition
CN102516233B (zh) * 2011-12-09 2014-04-09 北京联本医药化学技术有限公司 生产伏立康唑的方法
GR1007802B (el) * 2012-01-31 2013-01-18 Φαρματεν Αβεε, Μεθοδος για την παρασκευη παραγωγου της βρωμοπυρινιδινης
CN104884450B (zh) 2012-10-15 2017-03-29 辉瑞爱尔兰制药公司 制备伏立康唑及其类似物的方法
KR101435741B1 (ko) 2013-01-17 2014-08-29 (주) 에프엔지리서치 신규한 보리코나졸 중간체 및 이를 이용한 보리코나졸의 제조 방법
CN105503834B (zh) * 2015-12-23 2021-03-05 浙江华海药业股份有限公司 一种伏立康唑中间体的合成方法
CN106432198B (zh) 2016-09-08 2022-10-21 浙江华海药业股份有限公司 一种制备伏立康唑拆分中间体的方法
CN106632267B (zh) * 2016-11-09 2019-02-22 中国科学院成都生物研究所 一种伏立康唑的合成方法
CN108276310A (zh) * 2017-01-06 2018-07-13 常州齐晖药业有限公司 一种伏立康唑拆分剂(r)-10-樟脑磺酸的回收方法
CN108586433A (zh) * 2017-07-21 2018-09-28 齐鲁工业大学 具有抗菌活性的伏立康唑盐酸盐
CN109705102A (zh) * 2019-02-19 2019-05-03 浙江华海立诚药业有限公司 伏立康唑及其中间体的制备方法
CN110305113A (zh) * 2019-07-05 2019-10-08 镇江市第四人民医院（镇江市妇幼保健院） 一种伏立康唑杂质b的合成方法
CN112442017A (zh) * 2019-08-29 2021-03-05 珠海润都制药股份有限公司 一种采用微通道反应器制备伏立康唑消旋体的方法
CN110724130A (zh) * 2019-11-29 2020-01-24 怀化学院 伏立康唑及其中间体的合成方法
CN111440152B (zh) * 2020-05-18 2022-09-27 浙江诚意药业股份有限公司 一种伏立康唑的制备方法
CN112079819B (zh) * 2020-09-24 2022-06-17 南京易亨制药有限公司 一种改进的伏立康唑消旋体制备方法
CN112645935A (zh) * 2020-12-15 2021-04-13 植恩生物技术股份有限公司 伏立康唑关键中间体的制备方法
CN115724829A (zh) * 2022-12-23 2023-03-03 天津力生制药股份有限公司 一种分离真菌药物中间体杂质的液相色谱制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9002375D0 (en) * 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
EP0665225B1 (en) * 1994-02-01 1996-11-27 Ube Industries, Ltd. 4-Phenethylamino pyrimidine derivative, process for preparing the same and agricultural and horticultural chemical for controlling noxious organisms containing the same

Also Published As

Publication number Publication date
PL187227B1 (pl) 2004-06-30
PE16897A1 (es) 1997-05-21
NO980441L (no) 1998-03-26
DE69631160D1 (de) 2004-01-29
PL324922A1 (en) 1998-06-22
IL122462A0 (en) 1998-06-15
DE69631160T2 (de) 2004-07-08
CZ296975B6 (cs) 2006-08-16
TR199800170T1 (xx) 1998-06-22
ES2210382T3 (es) 2004-07-01
TW442480B (en) 2001-06-23
GB9516121D0 (en) 1995-10-04
EG21200A (en) 2001-01-31
IL122462A (en) 2001-10-31
AU703337B2 (en) 1999-03-25
US6586594B1 (en) 2003-07-01
BR9609960A (pt) 1999-02-02
KR100269048B1 (ko) 2000-10-16
CA2228655A1 (en) 1997-02-20
US6946555B2 (en) 2005-09-20
AU6740396A (en) 1997-03-05
IL131521A0 (en) 2001-01-28
CZ32798A3 (cs) 1999-03-17
NZ315651A (en) 1999-03-29
JP3224532B2 (ja) 2001-10-29
IN190817B (pt) 2003-08-23
NO314938B1 (no) 2003-06-16
JP3211965B2 (ja) 2001-09-25
JP2001026583A (ja) 2001-01-30
CA2228655C (en) 2003-09-09
MY123062A (en) 2006-05-31
EP0871625A1 (en) 1998-10-21
EP0871625B1 (en) 2003-12-17
HK1014944A1 (en) 1999-10-08
ZA966587B (en) 1998-02-02
DK0871625T3 (da) 2004-03-29
HUP9802766A2 (hu) 1999-02-01
JPH10510549A (ja) 1998-10-13
RU2156760C2 (ru) 2000-09-27
WO1997006160A1 (en) 1997-02-20
CN1076019C (zh) 2001-12-12
CN1195346A (zh) 1998-10-07
JP2001354670A (ja) 2001-12-25
KR19990036174A (ko) 1999-05-25
HUP9802766A3 (en) 2000-03-28
AR003472A1 (es) 1998-08-05
NO980441D0 (no) 1998-02-02
HU224339B1 (hu) 2005-08-29
MX9801025A (es) 1998-04-30
US20030181720A1 (en) 2003-09-25
IL131521A (en) 2001-08-08
ATE256679T1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
PT871625E (pt) Preparacao de triazoles por adicao organometalica a cetonas e intermediarios destas
LV11983A (lv) Iekskigi lietojams 2-metil-tieno-benzodiazepina zalu preparats
BR9606515A (pt) Composições biocidas transparentes de liberação contida
DE69608448T2 (de) Reduktion des biobewuchses
FI973750A0 (fi) 2-metyylitienobentsodiatsepiinin valmistus ja kiteiset muodot
BR9611130A (pt) Derivados de 3-aril-5-halógeno-pirona
IL118294A0 (en) Preparation of 4-aryl-piperidine derivatives
HUP9602510A1 (en) Preparation of substituted thiazoles
FI964193A (fi) Puriinien valmistaminen
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
FI970828A0 (fi) Spirostanyyliglykosidien kiteitä
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
PT589626E (pt) Preparacao de intermediarios beta-metil-carbapenem
IL117786A (en) Preparation of alpha-bisoximes
FI973341A0 (fi) Menetelmä organosilaanien valmistamiseksi
GB2305172B (en) Preparation of substituted thiazoles
NO974804L (no) Forbedringer ved vinduer
PT761766E (pt) Compostos assimetricos de trifenilenodioxazina
GB9521173D0 (en) Isolation of parasites
KR960019764U (ko) 진주목걸이의 구조
KR970043182U (ko) 기어의 구조
KR970043183U (ko) 기어의 구조
SV1993000010A (es) Preparacion de nuevas sulfonamidocarboxamidas
TW303813U (en) Modified structure of multi-functional assembled body
IL117639A0 (en) Preparation of cis-4-0-protected-2- cyclopentenol derivatives